Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-19-005825
Filing Date
2019-04-16
Accepted
2019-04-16 15:39:58
Documents
82
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K s117415_10k.htm 10-K 1333744
2 EXHIBIT 23.1 s117415_ex23-1.htm EX-23.1 2364
3 EXHIBIT 31.1 s117415_ex31-1.htm EX-31.1 10139
4 EXHIBIT 31.2 s117415_ex31-2.htm EX-31.2 10040
5 EXHIBIT 32.1 s117415_ex32-1.htm EX-32.1 4833
6 EXHIBIT 32.2 s117415_ex32-2.htm EX-32.2 5014
  Complete submission text file 0001615774-19-005825.txt   6502267

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bthe-20181231.xml EX-101.INS 1111278
8 XBRL SCHEMA FILE bthe-20181231.xsd EX-101.SCH 62013
9 XBRL CALCULATION FILE bthe-20181231_cal.xml EX-101.CAL 69084
10 XBRL DEFINITION FILE bthe-20181231_def.xml EX-101.DEF 317411
11 XBRL LABEL FILE bthe-20181231_lab.xml EX-101.LAB 513551
12 XBRL PRESENTATION FILE bthe-20181231_pre.xml EX-101.PRE 426453
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 19750963
SIC: 2834 Pharmaceutical Preparations